Why Cell and Gene Therapies Cost So Much – And What Can Be Done
Is Business Broken?
Navigating Access to Cell and Gene Therapies
This chapter explores the challenges and inefficiencies in accessing cell and gene therapies within the healthcare system. It highlights the importance of collaboration among patients, insurers, and policymakers to improve availability and alignment towards innovative solutions for better therapy access.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
